Description
EO 14398 COMPLIANCE TUBERCULOSIS IMMUNOLOGY RESEARCH & DEVELOPMENT
Base award description: TUBERCULOSIS IMMUNOLOGY RESEARCH & DEVELOPMENT
Modification chain · 8 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-02-23+$70,000= $70,000
- Mod P000012025-02-14+$0= $70,000
- Mod P000022025-10-01+$26,250= $96,250
- Mod P000032025-11-03+$6,563= $102,813
- Mod P000042025-12-18-$51,756= $51,056
- Mod P000052026-01-07+$0= $51,056
- Mod P000062026-02-06+$70,000= $121,056
- Mod P000072026-07-21+$0= $121,056
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-02-23 | +$70,000 | $70,000 | TUBERCULOSIS IMMUNOLOGY RESEARCH & DEVELOPMENT |
| Mod P00001· EXERCISE AN OPTION | 2025-02-14 | +$0 | $70,000 | TUBERCULOSIS IMMUNOLOGY RESEARCH & DEVELOPMENT - EXERCISE OPTION PERIOD 1. |
| Mod P00002· FUNDING ONLY ACTION | 2025-10-01 | +$26,250 | $96,250 | TUBERCULOSIS IMMUNOLOGY RESEARCH & DEVELOPMENT - EXERCISE OPTION PERIOD 1. |
| Mod P00003· FUNDING ONLY ACTION | 2025-11-03 | +$6,563 | $102,813 | TUBERCULOSIS IMMUNOLOGY RESEARCH & DEVELOPMENT - EXERCISE OPTION PERIOD 1. |
| Mod P00004· FUNDING ONLY ACTION | 2025-12-18 | −$51,756 | $51,056 | TUBERCULOSIS IMMUNOLOGY RESEARCH & DEVELOPMENT - EXERCISE OPTION PERIOD 1. |
| Mod P00005· OTHER ADMINISTRATIVE ACTION | 2026-01-07 | +$0 | $51,056 | TUBERCULOSIS IMMUNOLOGY RESEARCH & DEVELOPMENT - EXERCISE OPTION PERIOD 1. UPDATING INTERNAL PO NUMBER. |
| Mod P00006· EXERCISE AN OPTION | 2026-02-06 | +$70,000 | $121,056 | TUBERCULOSIS IMMUNOLOGY RESEARCH & DEVELOPMENT - EXERCISE OPTION PERIOD 2. |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-07-21 | +$0 | $121,056 | EO 14398 COMPLIANCE TUBERCULOSIS IMMUNOLOGY RESEARCH & DEVELOPMENT |
Related awards · 7
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI YVVTQD8CJC79)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24225P0458 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · AN11 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $27,040 | FY2025 |
| 36C24224C0149 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · AN42 · HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH | $1,260,960 | FY2024 |
| 36C24224P1575 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · AN11 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $3,600 | FY2024 |
| 36C24224P1122 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · AN11 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $10,525 | FY2024 |
| 36C24222C0012 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · Q511 · OPHTHALMOLOGY & OPTOMETRY | $3,015,207 | FY2022 |
Other recipients under AN11 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24923P1000 | INVIVOTEK LLC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $98,571 | FY2023 |
| 36C24921P0420 | NOVOGENE CORPORATION INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $9,072 | FY2021 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24924C0020_3600_-NONE-_-NONE- · retrieved 2026-09-26.